Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study.
- 2014-10-29
- Clinical Trial · n = 21
- Cancer immunology, immunotherapy : CII 64(2)
- Kathleen M Wesa
- Susanna Cunningham-Rundles
- Virginia M Klimek
- Emily Vertosick
- Marci I Coleton
- K Simon Yeung
- Hong Lin
- Stephen Nimer
- Barrie R Cassileth
- PubMed: 25351719
- DOI: 10.1007/s00262-014-1628-6
- Moderate evidence
- Clinical
Asymptomatic eosinophilia occurred in 4 patients (p = 0.014).
- Effect
- Neutral
- Effect size
- Small
- Significant
- Yes
- Dose
- 3 mg/kg twice daily